156 related articles for article (PubMed ID: 16457151)
1. Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.
Im SA; Lee KE; Nam E; Kim DY; Lee JH; Han HS; Seoh JY; Park HY; Cho MS; Han WS; Lee SN
Tumori; 2005; 91(6):513-21. PubMed ID: 16457151
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Significance of the Overexpression of HER-2/ neu in Korean Gastric Carcinomas and the In Vitro Effects of Anti-HER-2/neu Antibody on Cell Growth in the Gastric Carcinoma Cell Lines.
Im SA; Lee KE; Nam E; Nam SH; Kim DY; Seong CM; Park HY; Han WS; Seoh JY; Lee SN
Cancer Res Treat; 2003 Apr; 35(2):109-16. PubMed ID: 26680923
[TBL] [Abstract][Full Text] [Related]
3. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
4. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
5. [Molecular biology and immunohistochemical studies of Her2/neu oncogene in stomach cancer].
Jähne J; Urmacher C; Albino A; Meyer HJ; Pichlmayr R
Chirurg; 1994 Apr; 65(4):307-11. PubMed ID: 7912666
[TBL] [Abstract][Full Text] [Related]
6. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer.
Deng H; Wu RL; Zhou HY; Huang X; Chen Y; Liu LJ
World J Gastroenterol; 2006 Feb; 12(7):1013-7. PubMed ID: 16534839
[TBL] [Abstract][Full Text] [Related]
7. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
8. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis.
Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y
Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925
[TBL] [Abstract][Full Text] [Related]
9. Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma.
Bozzetti C; Negri FV; Lagrasta CA; Crafa P; Bassano C; Tamagnini I; Gardini G; Nizzoli R; Leonardi F; Gasparro D; Camisa R; Cavalli S; Silini EM; Ardizzoni A
Br J Cancer; 2011 Apr; 104(9):1372-6. PubMed ID: 21487407
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
11. Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma.
Jaehne J; Urmacher C; Thaler HT; Friedlander-Klar H; Cordon-Cardo C; Meyer HJ
J Cancer Res Clin Oncol; 1992; 118(6):474-9. PubMed ID: 1352299
[TBL] [Abstract][Full Text] [Related]
12. MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.
Zhang J; Guo L; Liu X; Li W; Ying J
Oncotarget; 2017 Feb; 8(6):10264-10273. PubMed ID: 28052014
[TBL] [Abstract][Full Text] [Related]
13. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
Allgayer H; Babic R; Gruetzner KU; Tarabichi A; Schildberg FW; Heiss MM
J Clin Oncol; 2000 Jun; 18(11):2201-9. PubMed ID: 10829039
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling.
Sajjadi E; Venetis K; Piciotti R; Gambini D; Blundo C; Runza L; Ferrero S; Guerini-Rocco E; Fusco N
BMC Cancer; 2021 Oct; 21(1):1152. PubMed ID: 34706703
[TBL] [Abstract][Full Text] [Related]
15. HER2 status in unusual histological variants of gastric adenocarcinomas.
Giuffrè G; Ieni A; Barresi V; Caruso RA; Tuccari G
J Clin Pathol; 2012 Mar; 65(3):237-41. PubMed ID: 22067088
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of HER-2 Protein is a High-Risk Factor for Patients with Surgically-Resected Stage T3 Gastric Adenocarcinoma.
Zhang Z; Wang B; Huang G; Wang R; Song J; Lin S; Wang W; Jiang Y; Huang Q; Wang L
Clin Lab; 2017 Jan; 63(1):115-125. PubMed ID: 28164509
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma.
Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S
World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.
Jin EH; Lee DH; Jung SA; Shim KN; Seo JY; Kim N; Shin CM; Yoon H; Jung HC
World J Gastroenterol; 2015 Jan; 21(2):571-7. PubMed ID: 25593477
[TBL] [Abstract][Full Text] [Related]
20. PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer.
Zhang X; Park JS; Park KH; Kim KH; Jung M; Chung HC; Rha SY; Kim HS
Oncology; 2015; 88(2):76-85. PubMed ID: 25300346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
